Trial Profile
Phase I trial of the gene therapy AAVrh 10 for cardiac dysfunction associated with Friedreich's ataxia.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 09 May 2014
Price :
$35
*
At a glance
- Drugs AAVrh-10 (Primary)
- Indications Friedreich's ataxia
- Focus Therapeutic Use
- Sponsors AAVLife
- 09 May 2014 New trial record